Structural Heart Devices Market Development And Business Intelligence

Summary

• Market Growth Factors & Global Market Size.
• Leading Players & Top Segments.
• Geographic Overview.

Market growth influenced due to following factors-

• rising prevalence of structural heart diseases.
• Regulatory approvals for new and advanced structural heart devices.
• Favorable reimbursement scenario for structural heart procedures & devices.
• Increasing awareness about structural heart diseases.

Global market size-

According to research report the global structural heart devices market is projected to reach USD 15.08 billion by 2023, at a CAGR of 10.2%. 

Leading Players-

Edwards Lifesciences Corporation (US), Medtronic plc (Ireland), Abbott (US), Boston Scientific Corporation (US), and LivaNova plc (UK) are the key players in the. The other players in this structural heart devices market are CryoLife, Inc. (US), Micro Interventional Devices, Inc. (US), Braile Biomédica (Brazil), Lepu Medical Technology (Beijing) Co., Ltd. (CHINA), and TTK Healthcare Limited (India).

Top Market Segments-

On the basis of procedure, the market has been broadly segmented into replacement procedures and repair procedures. The replacement procedures segment is further segmented into TAVR (transcatheter aortic valve replacement) procedures and SAVR (surgical aortic valve replacement) procedures, while the repair procedures segment is subdivided into closure procedures, annuloplasty, valvuloplasty, and TMVR procedures. The replacement procedures segment is expected to account for the largest share of the structural heart devices market in 2018. 

On the basis of products, the structural heart devices market is segmented into heart valve devices, occluders and delivery systems, annuloplasty rings, other devices, and accessories. The heart valve devices segment is further subdivided into transcatheter heart valves and surgical heart valves. The heart valve devices segment is expected to account for the largest market share in 2018.

For Details, Download PDF Brochure Here

Geographic Overview -

North America is expected to account for the largest share of the structural heart devices market in 2018, followed by Europe. The large share of North America in the global market is attributed to factors such as the rising prevalence of structural heart diseases, favorable reimbursement scenario for structural heart procedures and devices, technological advancements, and development of innovative devices.